atezolizumab
Pronunciation: A-teh-zoh-LIZ-yoo-mab
Other Name(s): Tecentriq™
Appearance: clear colourless or slightly yellow liquid solution
mixed into larger bags of fluids
Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Drug Monograph
May 2025
Eligibility Forms
Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer Atezolizumab - Adjuvant Treatment for Non-Small Cell Lung Cancer Atezolizumab - Adjuvant Treatment for Non-Small Cell Lung Cancer Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular CarcinomaPatient Info Sheet
May 2025
What it is used for
- Atezolizumab is used to treat certain types of cancers such as lung, liver, or breast cancers.
- Atezolizumab is an immune therapy drug. For more information on immune therapy, see Immunotherapy Medications: What you need to know.
- For information about treatments that include both atezolizumab and chemotherapy, see our Treating cancer with chemotherapy and immunotherapy: What you need to know guide.